CWI and Discharge After Breast Cancer Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02897934|
Recruitment Status : Completed
First Posted : September 13, 2016
Last Update Posted : February 2, 2021
The objectives of this work are threefold:
- To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery
- To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care
- To evaluate patient satisfaction with their care pathway
|Condition or disease||Intervention/treatment|
|Breast Cancer Pain||Drug: Bupivacaine continuous infusion|
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||Continuous Wound Infiltration and 23 Hour Discharge Following Major Breast Cancer Surgery|
|Study Start Date :||August 2016|
|Actual Primary Completion Date :||January 1, 2018|
|Actual Study Completion Date :||July 31, 2018|
- Drug: Bupivacaine continuous infusion
The use of continuous wound infusion of bupivacaineOther Name: marcain
- Pain [ Time Frame: 24 hours, 48 hours ]Pain will be recorded at at 24 and 48 hours using a slide-rule page on bespoke Android App. Pain will be recorded in a manner analogous to a visual analog scale 0 = No pain, 100 = Worst imaginable pain. Participants will be prompted on the first and second postoperative days to score their worst level of pain.
- Quality of recovery at 24 & 48 hours (QoR 40) [ Time Frame: 24 hours, 48 hours ]The quality of postoperative recovery from surgery and anaesthesia will be scored on the first and second postoperative day using the validated QoR 40 score. These metrics will be recorded on a bespoke Android App.
- Analgesic Consumption at 24 & 48 hours [ Time Frame: 24 hours, 48 hours ]The quantity of analgesics consumed on the first and second post operative day will be recorded, on a bespoke Android App.
- Wound drain output at 24 & 48 hours [ Time Frame: 24 hours, 48 hours ]Wound drain serous fluid output will be measured as is usual by the patient. These metrics will be recorded on a bespoke Android App.
- patient satisfaction [ Time Frame: 48 hours ]Patient satisfaction with their perioperative experience will be measured on a likert-type scale using a bespoke android app.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02897934
|Principal Investigator:||Brian O'Donnell, MD||Cork University Hospital|